Post-approval studies (Phase 4)WithdrawnNCT05974527
What this trial is testing
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Who this might be right for
AgitationSchizophreniaSchizoaffective Disorder+2 more
Brigham and Women's Hospital